Products for Research Use Only
RegisterLogin

Lifastuzumab vedotin

CAT: 0804-HY-P99705-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99705-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lifastuzumab vedotin (RG-7599; DNIB0600A) is an antibody-drug conjugate (ADC) that comprises a humanized IgG1 anti-NaPi2b monoclonal antibody (MNIB2126A) and a potent antimitotic agent, monomethyl auristatin E (MMAE), which inhibits cell division by blocking the polymerization of tubulin. Lifastuzumab vedotin has the potential for non-small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (PROC) research[1].
CAS Number
1401812-88-1
Product Name Alternative
RG-7599; DNIB-0600A; NaPi2b-ADC
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Field of Research
Cancer
Purity
99.03
Solubility
10 mM in DMSO
Smiles
[Lifastuzumabvedotin]
References & Citations
[1]S Banerjee, et al. Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study. Ann Oncol. 2018 Apr 1;29 (4) :917-923.|[2]David E Gerber, et al. Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer. Clin Cancer Res. 2020 Jan 15;26 (2) :364-372.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
ADC Related
Clinical Information
Phase 2

Related Products

CatalogName
HY-P99970-01Lifastuzumab
HY-P99662-01Indusatumab vedotin
HY-141602-01Pinatuzumab vedotin
HY-132253-01Polatuzumab vedotin
HY-P99595-01Sirtratumab vedotin
HY-145622-01Mecbotamab vedotin
HY-P99657Iladatuzumab vedotin
HY-P99454-01Azintuxizumab vedotin
HY-141604-01Glembatumumab vedotin
HY-P9985-01Disitamab vedotin

Alternative Products

CatalogName
D4010-1mgLifastuzumab vedotin
DHB65499Lifastuzumab vedotin (ADC)
591970Lifastuzumab Vedotin (SLC34A2)
GTR18401363-01Lifastuzumab vedotin Antibody
C00852-1mg*25Lifastuzumab vedotin (Anti-SLC34A2)
F1439-5Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab vedotin)
10-628Lifastuzumab Vedotin (SLC34A2) - Research Grade Biosimilar
GTR18315576NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin)
GTR18117460Lifastuzumab Vedotin (SLC34A2) - Research Grade Biosimilar Antibody
MBS9247242-01Anti-NaPi2b/SLC34A2 Reference Antibody (lifastuzumab vedotin)

Popular Products